Tag Archives: Recent

Weekly Roundup for JUNE 28, 2019: Recent Publications in Women’s Mental Health

Ketamine is the hot new antidepressant.  It has been shown to work quickly in patients with severe depression and can rapidly reduce suicidal ideation.  However, these studies have not been conducted in perinatal women; this group of women is typically excluded from clinical trials because there is typically very little information on the reproductive safety… Read More »

Future of flagship NHS global digital exemplar programme unclear, according to recent reports

Concerns have been raised about the future of the NHS global digital exemplar programme in England, according to a recent report in the Health Service Journal (HSJ). Through the scheme, a suite of acute, mental health and ambulance trusts have received funding – which has to be matched locally – to accelerate digital transformation and work with… Read More »

Weekly Roundup for MARCH 22, 2019: Recent Publications in Women’s Mental Health

The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup.  Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved specifically for the treatment of postpartum depression, there is considerable research to indicate that the modulation of neurosteroid systems may… Read More »